Cular interaction networks. Genome Res 2003, thirteen:2498?504. 32. Legrain P, Selig L: Genome-wide protein conversation maps employing twohybrid techniques. FEBS Lett 2000, 480:32?six. 33. Kahle JJ, Gulbahce N, Shaw CA, Lim J, Hill DE, Barabasi AL, Zoghbi HY: Comparison of an expanded ataxia interactome with affected individual health care documents reveals a romance among macular degeneration and ataxia. Hum Mol Genet 2011, twenty:510?27. 34. Tee JM, Peppelenbosch MP: Anchoring skeletal muscle mass growth and sickness: the part of ankyrin repeat domain made up of proteins in muscle mass physiology. Crit Rev Biochem Mol Biol 2010, 45:318?30. 35. Ogut O, Hossain MM, Jin JP: Interactions concerning nebulin-like motifs and slim filament regulatory proteins. J Biol Chem 2003, 278:3089?097. 36. Bader GD, Hogue CW: Analyzing yeast protein-protein interaction facts received from distinctive sources. Nat Biotechnol 2002, 20:991?97. 37. de Morree A, Hensbergen PJ, van Haagen HH, Dragan I, Deelder AM, Hoen PA t, Frants RR, van der Maarel SM: Proteomic examination on the PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/15501003 dysferlin protein complicated unveils its value for sarcolemmal upkeep and integrity. PLoS Just one 2010, five:e13854.Blandin et al. Skeletal Muscle mass 2013, 3:3 http://www.skeletalmusclejournal.com/content/3/1/Page 19 of38. van Haagen HH, Hoen PA t, de Morree A, van Roon-Mom WM, Peters DJ, Roos M, Mons B, van Ommen GJ, Schuemie MJ: In silico discovery and experimental validation of recent protein-protein interactions. Proteomics 2011, 11:843?53. 39. Cacciottolo M, Belcastro V, Laval S, Bushby K, di Bernardo D, Nigro V: Reverse engineering gene network identifies new dysferlin-interacting proteins. J Biol Chem 2011, 286:5404?413. forty. Comi GP, Fortunato F, Lucchiari S, Bordoni A, Prelle A, Jann S, Keller A, Ciscato P, Galbiati S, Chiveri L, et al: Beta-enolase deficiency, a completely new metabolic myopathy of distal glycolysis. Ann Neurol 2001, 50:202?07. 41. Palenzuela L, Andreu AL, Gamez J, Vila MR, Kunimatsu T, Meseguer A, Cervera C, Fernandez Cadenas I, van der Ven PF, Nygaard TG, et al: A novel autosomal dominant limb-girdle muscular dystrophy (LGMD 1F) maps to 7q32.1-32.two. Neurology 2003, sixty one:404?06. forty two. Tang BL, Zhang T, Minimal DY, Wong ET, Horstmann H, Hong W: Mammalian homologues of yeast sec31p. An ubiquitously expressed form is localized to endoplasmic reticulum (ER) exit sites and it is important for ERGolgi transport. J Biol Chem 2000, 275:13597?3604. 43. Starling A, Kok F, Passos-Bueno MR, Vainzof M, Zatz M: A new kind of autosomal dominant limb-girdle muscular dystrophy (LGMD1G) with progressive fingers and toes flexion limitation maps to chromosome 4p21. Eur J Hum Genet 2004, 12:1033?040. 44. Townley AK, Feng Y, Schmidt K, Carter DA, Porter R, Verkade P, Stephens DJ: Economical coupling of Sec23-Sec24 to Sec13-Sec31 Vindesine drives COPIIdependent collagen secretion which is essential for regular craniofacial development. J Cell Sci 2008, 121:3025?034. forty five. Kramerova I, Kudryashova E, Venkatraman G, Spencer MJ: Calpain three participates in sarcomere remodeling by acting upstream with the ubiquitin-proteasome pathway. Hum Mol Genet 2007, 16:1006. 46. Hack AA, Cordier L, Shoturma DI, Lam MY, Sweeney HL, McNally EM: Muscle degeneration without mechanical harm in sarcoglycan deficiency. Proc Natl Acad Sci U S A 1999, 96:10723?0728. 47. Barton ER: Restoration of gamma-sarcoglycan localization and mechanical sign transduction are unbiased in murine skeletal muscle mass. J Biol Chem 2010, 285:17263?7270. 48. Knoll R, Linke WA, Zou P, Miocic S, Kostin S, Buyan.